Arterial Catheter-Associated Proximal Ischemic Injury in Critically Ill Children: Evidence of Endothelial Dysfunction

Amelia Demopoulos1, Mark D Weber1,2, Hongyan Liu3

  • 1Division of Critical Care Medicine, Department of Anesthesia and Critical Care, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Insights

Arterial catheter-associated proximal ischemic injury (ACAPII) in pediatric patients with multiple organ dysfunction syndrome (MODS) is linked to immune dysregulation and endothelial dysfunction. These proteomic differences may offer therapeutic targets for preventing ACAPII.

Area of Science:

  • Pediatric critical care medicine
  • Proteomics and systems biology
  • Vascular access complications

Background:

  • Arterial catheter-associated proximal ischemic injury (ACAPII) is a severe complication in critically ill children requiring arterial access.
  • Understanding the underlying mechanisms of ACAPII is crucial for developing preventative strategies.
  • Multiple organ dysfunction syndrome (MODS) presents complex physiological challenges in pediatric patients.

Purpose of the Study:

  • To investigate proteomic differences in plasma samples from critically ill children with MODS who developed ACAPII versus those who did not.
  • To identify mechanistic pathways contributing to the pathogenesis of ACAPII in this vulnerable population.
  • To test the hypothesis that plasma proteome profiles at MODS onset differ between ACAPII and non-ACAPII groups.

Main Methods:

  • A single-center cohort study was conducted in a pediatric intensive care unit (PICU).
  • Plasma samples were collected within 48 hours of MODS onset from pediatric patients.
  • Proteomic analysis utilized Olink proximity extension assay, followed by gene set enrichment analysis.

Main Results:

  • ACAPII developed in 7.6% of MODS patients with arterial access.
  • Six immune dysregulation pathways (including STAT signaling and cytokine-mediated apoptosis) and five endothelial dysfunction pathways were significantly enriched in ACAPII cases.
  • Eighteen plasma proteins were differentially expressed in ACAPII patients, supporting roles for endothelial injury and immune dysregulation.

Conclusions:

  • Immune dysregulation and endothelial dysfunction pathways are associated with ACAPII in pediatric MODS patients.
  • These identified pathways precede the clinical manifestation of ACAPII, suggesting a potential therapeutic window.
  • Further research into these pathways could lead to novel treatments for preventing ACAPII.
Abstract